Precigen provides pipeline updates at the 39th annual j.p. morgan healthcare conference

Germantown, md., jan. 13, 2021 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today presented clinical and preclinical updates at the 39th annual j.p. morgan...
PGEN Ratings Summary
PGEN Quant Ranking